Skip to main content

Table 2 Eligibility criteria for patient participation in the Rhode Island collaborative practice agreement for naloxone (CPAN)

From: Orienting patients to greater opioid safety: models of community pharmacy-based naloxone

â–ª Voluntarily request

â–ª Recipient of emergency medical care for acute opioid poisoning

â–ª Suspected illicit or nonmedical opioid user

â–ª High dose opioid prescription (>100 morphine mg equivalents daily)

▪ Methadone prescription to opioid naïve patient

â–ª Dispensed an opioid prescription and:

 ▪ History of smoking

 ▪ COPD

 ▪ Respiratory illness or obstruction

 ▪ Renal dysfunction or hepatic disease

 ▪ Known or suspected concurrent alcohol abuse

 ▪ Concurrent benzodiazepine prescription

 ▪ Concurrent SSRI or TCA anti-depressant prescription

â–ª Recently released prisoners from a correctional facility

â–ª Released from opioid detoxification or mandatory abstinence program

â–ª Patients entering a methadone maintenance treatment program

â–ª Patients that may have difficulty accessing emergency medical services

  1. SOURCE: Rhode Island Board of Pharmacy, 2011